The transiency of metabolically healthy obesity: Metabolic decline and atherosclerotic risk

Diabetes Metab Res Rev. 2024 Feb;40(2):e3765. doi: 10.1002/dmrr.3765.

Authors

Saeid Mirzai¹, Ian J Neeland², Carl J Lavie³

Affiliations

¹ Section on Cardiovascular Medicine, Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.
² Harrington Heart and Vascular Institute, University Hospitals Cleveland Medical Center, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.
³ Department of Cardiovascular Diseases, John Ochsner Heart and Vascular Institute, Ochsner Clinical School-The University of Queensland School of Medicine, New Orleans, Los Angeles, USA.

PMID: 38598738
DOI: 10.1002/dmrr.3765

No abstract available

Keywords: cardiovascular disease; carotid atherosclerosis; metabolically healthy obesity.

Publication types

Editorial

MeSH terms

Atherosclerosis* / epidemiology
Atherosclerosis* / etiology
Atherosclerosis* / prevention & control
Body Mass Index
Humans
Metabolic Syndrome*
Obesity / complications
Obesity, Metabolically Benign* / complications
Risk Factors

Grants and funding

T32HL076132/National Heart, Lung, and Blood Institute of the National Institutes of Health